非药物干预对终末期肾病患者主动脉硬度的系统综述与荟萃分析
该系统综述与荟萃分析纳入33项研究共2166例终末期肾病患者,评估非药物干预对颈股脉搏波传导速度(cf-PWV)和收缩压(SBP)的影响。肾移植、生物阻抗控制液体超负荷、低钙透析液和透析中运动均可降低cf-PWV,其中肾移植和生物阻抗控制液体超负荷还降低SBP。证据质量从中等到极低不等。
要点
- 肾移植降低cf-PWV(-0.70 m/s)和SBP(-8.3 mmHg)。
- 生物阻抗控制液体超负荷降低cf-PWV(-1.90 m/s)和SBP(-4.3 mmHg)。
- 低钙透析液降低cf-PWV(-1.70 m/s),对SBP无显著影响。
核心结论
- 多种非药物干预可有效降低终末期肾病患者的主动脉硬度。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和EBM数据库,纳入33项研究(17项随机,16项非随机),共2166例终末期肾病患者。
主要发现
- 肾移植较移植前降低cf-PWV(-0.70 m/s;95%CI:-1.3至-0.11;P=0.02)和SBP(-8.3 mmHg;95%CI:-13.2至-3.3;P<0.001)。
- 随机试验中,生物阻抗控制液体超负荷较仅临床评估降低cf-PWV(-1.90 m/s;95%CI:-3.3至-0.5;P=0.02)和SBP(-4.3 mmHg;95%CI:-7.7至-0.93;P=0.01)。
- 横断面研究显示正常容量状态较超负荷状态cf-PWV和SBP显著更低(P≤0.01)。
- 低钙透析液降低cf-PWV(-1.70 m/s;95%CI:-2.4至-1.0;P<0.00001),对SBP无显著影响(-1.6 mmHg;95%CI:-8.9至5.8;P=0.61)。
- 透析中运动较不运动降低cf-PWV(-1.13 m/s;95%CI:-2.2至-0.03;P=0.04),对SBP无显著影响(+0.5 mmHg;95%CI:-9.5至10.4;P=0.93)。
关键数值与推荐
- 证据质量范围为极低至中等。
临床怎么用
- 对于终末期肾病患者,可考虑肾移植、生物阻抗指导的液体管理、低钙透析液和透析中运动以改善主动脉硬度。
局限性
- 纳入研究包括非随机设计,证据质量多为低至极低。
- 这些干预对心血管结局和死亡率的影响尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Increased carotid-femoral pulse wave velocity (cf-PWV) in end-stage renal disease (ESRD) indicates enhanced aortic stiffness and mortality risk. We conducted a systematic review and meta-analysis of nonpharmacologic interventions in adults with ESRD to determine their effects on cf-PWV, systolic blood pressure (SBP), and intervention-associated adverse events. METHODS: MEDLINE, EMBASE, and EBM databases were searched. Study screening, selection, data collection, and methodological quality assessments were performed by 2 independent reviewers. Pooled-effect estimates from mean differences and 95% confidence intervals (CIs) were calculated using random effect models. RESULTS: A total of 2166 subjects with ESRD from 33 studies (17 randomized; 16 nonrandomized) were included. Four intervention-comparator pairs were meta-analyzed. Quality of evidence ranged from very low to moderate. Kidney transplantation decreased cf-PWV (-0.70 m/s; CI: -1.3 to -0.11; P = 0.02) and SBP (-8.3 mm Hg; CI: -13.2 to -3.3; P < 0.001) over pretransplantation. In randomized trials, control of fluid overload by bio-impedance reduced cf-PWV (-1.90 m/s; CI: -3.3 to -0.5); P = 0.02) and SBP (-4.3 mm Hg; CI: -7.7 to -0.93); P = 0.01) compared with clinical assessment alone. Cross-sectional studies also demonstrated significantly lower cf-PWV and SBP in normovolemia compared with hypervolemia (P ≤ 0.01). Low calcium dialysate decreased cf-PWV (-1.70 m/s; CI: -2.4 to -1.0; P < 0.00001) without affecting SBP (-1.6 mm Hg; CI: -8.9 to 5.8; P = 0.61). Intradialytic exercise compared with no exercise reduced cf-PWV (-1.13 m/s; CI: -2.2 to -0.03; P = 0.04), but not SBP (+0.5 mm Hg; CI: -9.5 to 10.4); P = 0.93). CONCLUSIONS: Several nonpharmacologic interventions effectively decrease aortic stiffness in ESRD. The impact of these interventions on cardiovascular outcomes and mortality risk reduction in ESRD requires further study.
引用
- Rodriguez RA, Hae R, Spence M, et al. A Systematic Review and Meta-analysis of Nonpharmacologic-based Interventions for Aortic Stiffness in End-Stage Renal Disease. Kidney Int Rep. 2019. PMID: 31440701. doi:10.1016/j.ekir.2019.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。